Skip to main content
Erschienen in: Internal and Emergency Medicine 1/2021

27.03.2020 | IM - ORIGINAL

Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction

verfasst von: Giovanni Cioffi, Ombretta Viapiana, Luigi Tarantini, Federica Ognibeni, Giovanni Orsolini, Angelo Fassio, Davide Gatti, Maurizio Rossini, Alessandro Giollo

Erschienen in: Internal and Emergency Medicine | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Inflammatory arthritis, including rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS), are associated with both cancer and cardiovascular (CV) adverse events. Cancer and CV abnormalities have coincident etiologic and pathophysiologic pathways in RA/PsA/AS patients. However, a comprehensive evaluation of CV system has never been performed in these patients in relation to the presence of cancer. This study was designed to assess the possible relationships between CV abnormalities and cancer among RA/PsA/AS patients. Between March 2014 and March 2015, 414 patients (214 RA, 125 PsA, and 75 SA) in sinus rhythm without known cardiac disease underwent clinical and color Doppler echocardiographic evaluation and were prospectively followed up. Patients had a mean age of 58 ± 12 years, 64% women. Forty-two patients (10.1%) had a diagnosis of cancer (made before enrollment in 24 cases and in 18 cases during the 36 months of follow-up). Skin cancer was the most frequent malignancy found, followed by thyroid, colon, pancreas, and breast cancer. Patients who had cancer were older with higher systolic blood pressure, more frequent hypertension and moderate/high disease activity, left ventricular (LV) hypertrophy, diastolic dysfunction, and higher ascending aortic stiffness index (AOSI) than those who had not. At multivariate logistic regression analysis, LV diastolic dysfunction and abnormally high AOSI emerged as conditions associated with cancer together with older age and hypertension. Cancer in RA/PsA/AS adults without history of CV disease is closely associated with specific asymptomatic CV abnormalities, such as LV diastolic dysfunction and reduced vascular elasticity, which are independent of age and hypertension.
Literatur
2.
Zurück zum Zitat Turesson C, Matteson EL (2013) Malignancy as a comorbidity in rheumatic diseases. Rheumatology 52:5–14PubMed Turesson C, Matteson EL (2013) Malignancy as a comorbidity in rheumatic diseases. Rheumatology 52:5–14PubMed
3.
Zurück zum Zitat Gross RL, Schwartzman-Morris JS, Krathen M, Reed G, Chang H, Saunders KC, Fisher MC, Greenberg JD, Putterman C, Mease PJ, Gottlieb AB, Kremer JM, Broder A (2014) A comparison of the malignancy incidence among patients with psoriatic arthritis and patients with rheumatoid arthritis in a large US cohort. Arthritis Rheumatol 66:1472–1481PubMedPubMedCentral Gross RL, Schwartzman-Morris JS, Krathen M, Reed G, Chang H, Saunders KC, Fisher MC, Greenberg JD, Putterman C, Mease PJ, Gottlieb AB, Kremer JM, Broder A (2014) A comparison of the malignancy incidence among patients with psoriatic arthritis and patients with rheumatoid arthritis in a large US cohort. Arthritis Rheumatol 66:1472–1481PubMedPubMedCentral
4.
Zurück zum Zitat Rohekar S, Tom BD, Hassa A, Schentag CT, Farewell VT, Gladman DD (2008) Prevalence of malignancy in psoriatic arthritis. Arthritis Rheum 58:82–87PubMed Rohekar S, Tom BD, Hassa A, Schentag CT, Farewell VT, Gladman DD (2008) Prevalence of malignancy in psoriatic arthritis. Arthritis Rheum 58:82–87PubMed
5.
Zurück zum Zitat Feltelius N, Ekbom A, Blomqvist P (2003) Cancer incidence among patients with ankylosing spondylitis in Sweden 1965–1995: a population based cohort study. Ann Rheum Dis 62:1185–1188PubMedPubMedCentral Feltelius N, Ekbom A, Blomqvist P (2003) Cancer incidence among patients with ankylosing spondylitis in Sweden 1965–1995: a population based cohort study. Ann Rheum Dis 62:1185–1188PubMedPubMedCentral
6.
Zurück zum Zitat Dommasch ED, Abuabara K, Shin DB, Nguyen J, Troxel AB, Gelfand JM (2011) The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials. J Am Acad Dermatol 64:1035–1050PubMedPubMedCentral Dommasch ED, Abuabara K, Shin DB, Nguyen J, Troxel AB, Gelfand JM (2011) The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials. J Am Acad Dermatol 64:1035–1050PubMedPubMedCentral
7.
Zurück zum Zitat Tu H, Wen CP, Tsai SP, Chow WH, Wen C, Ye Y, Zhao H, Tsai MK, Huang M, Dinney CP, Tsao CK, Wu X (2018) Cancer risk associated with chronic diseases and disease markers: prospective cohort study. BMJ 360:134–145 Tu H, Wen CP, Tsai SP, Chow WH, Wen C, Ye Y, Zhao H, Tsai MK, Huang M, Dinney CP, Tsao CK, Wu X (2018) Cancer risk associated with chronic diseases and disease markers: prospective cohort study. BMJ 360:134–145
8.
Zurück zum Zitat Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674PubMed Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674PubMed
9.
Zurück zum Zitat Balkwill FR, Mantovani A (2012) Cancer-related inflammation: common themes and therapeutic opportunities. Semin Cancer Biol 22:33–40PubMed Balkwill FR, Mantovani A (2012) Cancer-related inflammation: common themes and therapeutic opportunities. Semin Cancer Biol 22:33–40PubMed
10.
Zurück zum Zitat Balkwill F (2009) Tumour necrosis factor and cancer. Nat Rev Cancer 9:361–371PubMed Balkwill F (2009) Tumour necrosis factor and cancer. Nat Rev Cancer 9:361–371PubMed
11.
Zurück zum Zitat Dougados M, Betteridge N, Burmester GR, Euller-Ziegler L, Guillemin F, Hirvonen J et al (2004) EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees. Ann Rheum Dis 63:1172–1176PubMedPubMedCentral Dougados M, Betteridge N, Burmester GR, Euller-Ziegler L, Guillemin F, Hirvonen J et al (2004) EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees. Ann Rheum Dis 63:1172–1176PubMedPubMedCentral
12.
Zurück zum Zitat Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59:1690–1697PubMed Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59:1690–1697PubMed
13.
Zurück zum Zitat van Halm VP, Peters MJ, Voskuyl BM, Lems WF, Visser M et al (2009) Rheumatoid arthritis versus type 2 diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE investigation. Ann Rheum Dis 68:1395–1400PubMed van Halm VP, Peters MJ, Voskuyl BM, Lems WF, Visser M et al (2009) Rheumatoid arthritis versus type 2 diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE investigation. Ann Rheum Dis 68:1395–1400PubMed
14.
Zurück zum Zitat Cioffi G, Viapiana O, Ognibeni F, Dalbeni A, Giollo A, Gatti D, Idolazzi L, Faganello G, Di Lenarda A, Rossini M (2017) Prognostic role of subclinical left ventricular systolic dysfunction evaluated by speckle-tracking echocardiography in rheumatoid arthritis. J Am Soc Echocardiogr 30:602–611PubMed Cioffi G, Viapiana O, Ognibeni F, Dalbeni A, Giollo A, Gatti D, Idolazzi L, Faganello G, Di Lenarda A, Rossini M (2017) Prognostic role of subclinical left ventricular systolic dysfunction evaluated by speckle-tracking echocardiography in rheumatoid arthritis. J Am Soc Echocardiogr 30:602–611PubMed
15.
Zurück zum Zitat Cioffi G, Viapiana O, Ognibeni F, Dalbeni A, Orsolini G, Adami S, Gatti D, Fisicaro M, Tarantini L, Rossini M (2016) Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness. Eur J Prev Cardiol 23:1848–1859PubMed Cioffi G, Viapiana O, Ognibeni F, Dalbeni A, Orsolini G, Adami S, Gatti D, Fisicaro M, Tarantini L, Rossini M (2016) Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness. Eur J Prev Cardiol 23:1848–1859PubMed
16.
Zurück zum Zitat Solomon DH, Goodson NJ, Katz JN, Weinblatt ME, Avorn J, Setoguchi S et al (2006) Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis 65:1608–1612PubMedPubMedCentral Solomon DH, Goodson NJ, Katz JN, Weinblatt ME, Avorn J, Setoguchi S et al (2006) Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis 65:1608–1612PubMedPubMedCentral
17.
Zurück zum Zitat Wong M, Toh L, Wilson A, Rowley K, Karschimkus C, Prior D et al (2003) Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation. Arthritis Rheum 48:81–89PubMed Wong M, Toh L, Wilson A, Rowley K, Karschimkus C, Prior D et al (2003) Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation. Arthritis Rheum 48:81–89PubMed
18.
Zurück zum Zitat Nagata-Sakurai M, Inaba M, Goto H, Kumeda Y, Furumitsu Y, Inui K et al (2003) Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis. Arthritis Rheum 48:3061–3067PubMed Nagata-Sakurai M, Inaba M, Goto H, Kumeda Y, Furumitsu Y, Inui K et al (2003) Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis. Arthritis Rheum 48:3061–3067PubMed
19.
Zurück zum Zitat Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, Piñeiro A, Garcia-Porrua C, Miranda-Filloy JA et al (2007) HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 57:125–132PubMed Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, Piñeiro A, Garcia-Porrua C, Miranda-Filloy JA et al (2007) HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 57:125–132PubMed
20.
Zurück zum Zitat Kreatsoulas C, Anand SS, Subramanian SV (2014) An emerging double burden of disease: the prevalence of individuals with cardiovascular disease and cancer. J Intern Med 275:494–505PubMed Kreatsoulas C, Anand SS, Subramanian SV (2014) An emerging double burden of disease: the prevalence of individuals with cardiovascular disease and cancer. J Intern Med 275:494–505PubMed
21.
Zurück zum Zitat Armenian SH, Xu L, Ky B, Sun C, Farol LT, Pal SK, Douglas PS, Bhatia S, Chao C (2016) Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study. J Clin Oncol 34:1122–1130PubMedPubMedCentral Armenian SH, Xu L, Ky B, Sun C, Farol LT, Pal SK, Douglas PS, Bhatia S, Chao C (2016) Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study. J Clin Oncol 34:1122–1130PubMedPubMedCentral
22.
Zurück zum Zitat Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581PubMed Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581PubMed
23.
Zurück zum Zitat Rudwaleit M, Taylor WJ (2010) Classification criteria for psoriatic arthritis and ankylosing spondylitis/axial spondyloarthritis. Best Pract Res Clin Rheumatol 24:589–604PubMed Rudwaleit M, Taylor WJ (2010) Classification criteria for psoriatic arthritis and ankylosing spondylitis/axial spondyloarthritis. Best Pract Res Clin Rheumatol 24:589–604PubMed
24.
Zurück zum Zitat Kearsley-Fleet L, Davies R, De Cock D, Watson KD, Lunt M, Buch MH et al (2018) BSRBR-RA Contributors Group. Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Ann Rheum Dis 77:1405–1412PubMed Kearsley-Fleet L, Davies R, De Cock D, Watson KD, Lunt M, Buch MH et al (2018) BSRBR-RA Contributors Group. Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Ann Rheum Dis 77:1405–1412PubMed
25.
Zurück zum Zitat Dhaon P, Das SK, Srivastava R, Dhakad U (2018) Performances of clinical disease activity index (CDAI) and simplified disease activity index (SDAI) appear to be better than the gold standard disease assessment score (DAS-28-CRP) to assess rheumatoid arthritis patients. Int J Rheum Dis 21:1933–1939PubMed Dhaon P, Das SK, Srivastava R, Dhakad U (2018) Performances of clinical disease activity index (CDAI) and simplified disease activity index (SDAI) appear to be better than the gold standard disease assessment score (DAS-28-CRP) to assess rheumatoid arthritis patients. Int J Rheum Dis 21:1933–1939PubMed
26.
Zurück zum Zitat Smolen JS, Aletaha D (2014) Scores for all seasons: SDAI and CDAI. Clin Exp Rheumatol 32:S75–79 Smolen JS, Aletaha D (2014) Scores for all seasons: SDAI and CDAI. Clin Exp Rheumatol 32:S75–79
27.
Zurück zum Zitat Palmieri L, Panico S, Vanuzzo D, Ferrario M, Pilotto L, Sega R, Gruppo di Ricerca del Progetto CUORE (2004) Evaluation of the global cardiovascular absolute risk: the Progetto CUORE individual score. Ann Super Sanita 40:393–399 Palmieri L, Panico S, Vanuzzo D, Ferrario M, Pilotto L, Sega R, Gruppo di Ricerca del Progetto CUORE (2004) Evaluation of the global cardiovascular absolute risk: the Progetto CUORE individual score. Ann Super Sanita 40:393–399
28.
Zurück zum Zitat Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I et al (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458PubMed Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I et al (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458PubMed
29.
Zurück zum Zitat de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH (1995) Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 25:1056–1062PubMed de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH (1995) Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 25:1056–1062PubMed
30.
Zurück zum Zitat de Simone G, Daniels SR, Kimball TR, Roman MJ, Romano C, Chinali M et al (2005) Evaluation of concentric left ventricular geometry in humans: evidence for age-related systematic underestimation. Hypertension 45:64–68PubMed de Simone G, Daniels SR, Kimball TR, Roman MJ, Romano C, Chinali M et al (2005) Evaluation of concentric left ventricular geometry in humans: evidence for age-related systematic underestimation. Hypertension 45:64–68PubMed
31.
Zurück zum Zitat de Simone G, Devereux RB, Roman MJ, Ganau A, Saba SP, Alderman MH et al (1994) Assessment of left ventricular function by the midwall fractional shortening/end systolic stress relation in human hypertension. J Am Coll Cardiol 23:1444–1451PubMed de Simone G, Devereux RB, Roman MJ, Ganau A, Saba SP, Alderman MH et al (1994) Assessment of left ventricular function by the midwall fractional shortening/end systolic stress relation in human hypertension. J Am Coll Cardiol 23:1444–1451PubMed
32.
Zurück zum Zitat Cioffi G, Viapiana O, Ognibeni F, Fracassi E, Giollo A, Adami S, Gatti D, Mazzone C, Faganello G, Lenarda AD, Rossini M (2016) Prevalence and factors associated with subclinical left ventricular systolic dysfunction evaluated by mid-wall mechanics in rheumatoid arthritis. Echocardiography 33:1290–1299PubMed Cioffi G, Viapiana O, Ognibeni F, Fracassi E, Giollo A, Adami S, Gatti D, Mazzone C, Faganello G, Lenarda AD, Rossini M (2016) Prevalence and factors associated with subclinical left ventricular systolic dysfunction evaluated by mid-wall mechanics in rheumatoid arthritis. Echocardiography 33:1290–1299PubMed
33.
Zurück zum Zitat Cioffi G, Viapiana O, Ognibeni F, Dalbeni A, Gatti D, Mazzone C, Faganello G, Di Lenarda A, Adami S, Rossini M (2016) Combined circumferential and longitudinal left ventricular systolic dysfunction in patients with rheumatoid arthritis without overt cardiac disease. J Am Soc Echocardiogr 29:689–698PubMed Cioffi G, Viapiana O, Ognibeni F, Dalbeni A, Gatti D, Mazzone C, Faganello G, Di Lenarda A, Adami S, Rossini M (2016) Combined circumferential and longitudinal left ventricular systolic dysfunction in patients with rheumatoid arthritis without overt cardiac disease. J Am Soc Echocardiogr 29:689–698PubMed
34.
Zurück zum Zitat Cioffi G, Viapiana O, Ognibeni F, Dalbeni A, Gatti D, Adami S, Mazzone C, Faganello G, Di Lenarda A, Rossini M (2015) Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis. A prospective tissue Doppler echocardiography study. Herz 40:989–996PubMed Cioffi G, Viapiana O, Ognibeni F, Dalbeni A, Gatti D, Adami S, Mazzone C, Faganello G, Di Lenarda A, Rossini M (2015) Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis. A prospective tissue Doppler echocardiography study. Herz 40:989–996PubMed
35.
Zurück zum Zitat Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29:277–314PubMed Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29:277–314PubMed
36.
Zurück zum Zitat Wallberg-Jonsson S, Johansson H, Ohman ML, Rantapaa-Dahlqvist S (1999) Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis: A retrospective cohort study from disease onset. J Rheumatol 26:2562–2571PubMed Wallberg-Jonsson S, Johansson H, Ohman ML, Rantapaa-Dahlqvist S (1999) Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis: A retrospective cohort study from disease onset. J Rheumatol 26:2562–2571PubMed
37.
Zurück zum Zitat Campia U, Moslehi JJ, Amiri-Kordestani L, Barac A, Beckman JA, Chism DD, Cohen P, Groarke JD, Herrmann J, Reilly CM, Weintraub NL (2019) Cardio-oncology: vascular and metabolic perspectives: a scientific statement from the american heart association. Circulation 139:e579–e602PubMedPubMedCentral Campia U, Moslehi JJ, Amiri-Kordestani L, Barac A, Beckman JA, Chism DD, Cohen P, Groarke JD, Herrmann J, Reilly CM, Weintraub NL (2019) Cardio-oncology: vascular and metabolic perspectives: a scientific statement from the american heart association. Circulation 139:e579–e602PubMedPubMedCentral
38.
Zurück zum Zitat Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GYH, Lyon AR, Lopez Fernandez T, Mohty D, Piepoli MF, Tamargo J, Torbicki A, Suter TM; ESC Scientific Document Group (2016) ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 2016(37):2768–2801 Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GYH, Lyon AR, Lopez Fernandez T, Mohty D, Piepoli MF, Tamargo J, Torbicki A, Suter TM; ESC Scientific Document Group (2016) ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 2016(37):2768–2801
39.
Zurück zum Zitat Sitia S, Tomasoni L, Cicala S, Atzeni F, Ricci C, Gaeta M et al (2012) Detection of preclinical impairment of myocardial function in rheumatoid arthritis patients with short disease duration by speckle tracking echocardiography. Int J Cardiol 160:8–14PubMed Sitia S, Tomasoni L, Cicala S, Atzeni F, Ricci C, Gaeta M et al (2012) Detection of preclinical impairment of myocardial function in rheumatoid arthritis patients with short disease duration by speckle tracking echocardiography. Int J Cardiol 160:8–14PubMed
40.
Zurück zum Zitat Fine NM, Crowson CS, Lin G, Oh JK, Villarraga HR, Gabriel SE (2014) Evaluation of myocardial function in patients with rheumatoid arthritis using strain imaging by speckle-tracking echocardiography. Ann Rheum Dis 73:1833–1839PubMed Fine NM, Crowson CS, Lin G, Oh JK, Villarraga HR, Gabriel SE (2014) Evaluation of myocardial function in patients with rheumatoid arthritis using strain imaging by speckle-tracking echocardiography. Ann Rheum Dis 73:1833–1839PubMed
41.
Zurück zum Zitat Kobayashi H, Kobayashi Y, Giles JT, Yoneyama K, Nakajima Y, Takei M (2014) Tocilizumab treatment increases left ventricular ejection fraction and decreases left ventricular mass index in patients with rheumatoid arthritis without cardiac symptoms: assessed using 3.0 tesla cardiac magnetic resonance imaging. J Rheumatol 41:1916–1921PubMed Kobayashi H, Kobayashi Y, Giles JT, Yoneyama K, Nakajima Y, Takei M (2014) Tocilizumab treatment increases left ventricular ejection fraction and decreases left ventricular mass index in patients with rheumatoid arthritis without cardiac symptoms: assessed using 3.0 tesla cardiac magnetic resonance imaging. J Rheumatol 41:1916–1921PubMed
42.
Zurück zum Zitat Ikonomidis I, Lekakis JP, Nikolaou M, Paraskevaidis I, Andreadou I, Kaplanoglou T et al (2008) Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis. Circulation 117:2662–2669PubMed Ikonomidis I, Lekakis JP, Nikolaou M, Paraskevaidis I, Andreadou I, Kaplanoglou T et al (2008) Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis. Circulation 117:2662–2669PubMed
43.
Zurück zum Zitat Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436–444PubMed Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436–444PubMed
44.
Zurück zum Zitat Sodir NM, Swigart LB, Karnezis AN, Hanahan D, Evan GI, Soucek L (2011) Endogenous Myc maintains the tumor microenvironment. Genes Dev 25:907–916PubMedPubMedCentral Sodir NM, Swigart LB, Karnezis AN, Hanahan D, Evan GI, Soucek L (2011) Endogenous Myc maintains the tumor microenvironment. Genes Dev 25:907–916PubMedPubMedCentral
45.
Zurück zum Zitat Fantò M, Peragallo MS, Pietrosanti M, Di Rosa R, Picchianti Diamanti A, Salemi S, D'Amelio R (2016) Risk of malignancy in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under immunosuppressive therapy: a single-center experience. Intern Emerg Med 11:31–40PubMed Fantò M, Peragallo MS, Pietrosanti M, Di Rosa R, Picchianti Diamanti A, Salemi S, D'Amelio R (2016) Risk of malignancy in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under immunosuppressive therapy: a single-center experience. Intern Emerg Med 11:31–40PubMed
Metadaten
Titel
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction
verfasst von
Giovanni Cioffi
Ombretta Viapiana
Luigi Tarantini
Federica Ognibeni
Giovanni Orsolini
Angelo Fassio
Davide Gatti
Maurizio Rossini
Alessandro Giollo
Publikationsdatum
27.03.2020
Verlag
Springer International Publishing
Erschienen in
Internal and Emergency Medicine / Ausgabe 1/2021
Print ISSN: 1828-0447
Elektronische ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-020-02310-6

Weitere Artikel der Ausgabe 1/2021

Internal and Emergency Medicine 1/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.